Heffes, Ellen M.; Livingston, Phil
June 2001
Financial Executive;Jun2001, Vol. 17 Issue 4, p25
Academic Journal
An interview with David L. Shedlarz, the executive vice president and chief financial officer of the pharmaceutical company Pfizer Inc. is presented. Shedlarz discusses the merger with Warner-Lambert Co. in November 1999 and the resulting events encompassing the pharmaceutical industry. He also describes what role he played in the merging process and specific factors which led up to it. INSET: DETAILS OF THE DEAL.


Related Articles

  • Pfizer, Warner-Lambert merger to be completed this month. Garza, Daniel R. // Caribbean Business;6/1/2000, Vol. 28 Issue 21, p14 

    Reports that the merger deal between pharmaceutical firms Pfizer Inc. and Warner-Lambert Inc. will be completed in June 2000. Expected approval of the merger deal by the United States Federal Trade Commission; Corporate synergies to be created from the merger deal; Range of products controlled...

  • Since money `talks', so does Warner-Lambert and Pfizer; agreement appears likely.  // Medical Marketing & Media;Feb2000, Vol. 35 Issue 2, p6 

    Reports that the Warner-Lambert board of directors have authorized management to negotiate with Pfizer on its unsolicited takeover bid. Previous agreement of Warner-Lambert to merge with American Home Products; Possible payment of break-up fee.

  • Bigger is Better. Seiden, Carl // Medical Marketing & Media;May2000, Vol. 35 Issue 5, p64 

    Reports on the benefits of the consolidation of the pharmaceutical industry in the United States. Merger between Pfizer Inc. and Warner-Lambert Co.; Merger of companies for financial reasons; Mergers' reduction of operating expenses.

  • Pfizer's prospects look good without Lambert. Gandel, Stephen // Crain's New York Business;11/08/99, Vol. 15 Issue 45, p4 

    Focuses on Pfizer Inc.'s unsolicited all-stock bid to take over rival Warner-Lambert Co., which will create the largest drug company in the world. Pros and cons of the merger; Estimated Pfizer's earnings per share, before a Warner merger, in 1999 and 200; Sales of the combined company; Number...

  • Is Pharma M&A the Key to Strengthening the Pipeline? Van Arnum, Patricia // Chemical Market Reporter;08/21/2000, Vol. 258 Issue 8, pFR3 

    Focuses on whether pharmaceutical mergers and acquisitions (M&A) will strengthen the drug industry. Projected spending of the industry on research and development (R&D) in 2000; Reason for the acceleration in pharmaceutical M&A; Estimated total global pharmaceutical transactions in 1999; List...

  • Pfizer, Warner-Lambert merger forms pharmaceutical powerhouse. Roller, Kim; Frederick, James // Drug Store News;3/6/2000, Vol. 22 Issue 3, p15 

    Provides information on the merger between Pfizer and Warner-Lambert which aims to establish leadership in major therapeutic areas. Projected annual revenues of the merged company; Products to be offered by the merged company; Cost savings of Pfizer from the merger; Categories of disorders...

  • Pfizer exercises its bragging rights, seven billion-dollar drugs.  // Medical Marketing & Media;Jun2000, Vol. 35 Issue 6, p16 

    Reports on Pfizer shareholders' approval of the company's plan to acquire Warner-Lambert Co. Value of the deal; Growth of the company in 1999; Financial performance; Pfizer-manufactured drugs that have reached the billion-dollar mark.

  • Pfizer Bags Warner-Lambert To Form #2 Global Pharma Giant. Mirasol, Feliza // Chemical Market Reporter;02/14/2000, Vol. 257 Issue 7, p1 

    Reports the merger of pharmaceutical companies Warner-Lambert Co. and Pfizer Inc. Details on the merger agreement; Terms and value of the deal; Information on both companies.

  • The marriage that was not to be. Goldblatt, Dan // Business News New Jersey;02/08/2000, Vol. 13 Issue 6, p6 

    Reports on the merger deal between New Jersey-based pharmaceutical company Warner-Lambert and New York City-based drugmaker Pfizer. Previous merger agreement between Warner-Lambert and American Home Products (AHP); Pfizer's initial and final bid for Warner-Lambert; Price for terminating the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics